Patients from one of Australia's largest IVF clinics are seeking compensation following a data breach earlier this year.
Experts worry early detection tests like Galleri and CancerGuard are unproven and could drive up health care costs by ...
Published in the Oct. 30, 2025 edition of Frontiers in Pharmacology, the new post-hoc analysis showed that patients who took the GeneSight test were at any given time during the 24-week study period ...
Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.
Discover how AI-driven blood testing is revolutionizing diagnostics by offering personalized health insights and ...
The American Cancer Society says women in their 70s have the highest risk of breast cancer diagnosis at 4.2%. That’s one in ...
The hospital system is betting the move will give it better control over turnaround time and allow it to be more "nimble" in ...
Anwar Adow, 25, is convicted of wire fraud after admitting his company — Liberty Plus LLC — billed Medicaid $1.2 million for ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2025 earnings conference call at 4:30 pm ET on Monday, Nov. 3, 2025.
Investor's Business Daily on MSN
Will This Genetic Testing Name's Profit Soar 950%? Earnings Are On Deck.
This medical services stock is nearing a buy point. It has shown tremendous profit growth over the last few quarters.
The procedure’s punishing price tag, even for many with insurance, has led thousands of patients to try money-saving hacks.
An "exciting milestone" has been reached in the development of a new medical testing centre set to open this year. All 13 modular units which will make up the building of the community diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback